ASPEN is a multinational, randomized, double-blind, placebo-controlled, parallel-group study that is evaluating the frequency and severity of exacerbations as well as the safety and tolerability of long-term (52-week) treatment with brensocatib compared with placebo in patients with non-cystic fibrosis bronchiectasis
But meanwhile, many physicians and researchers are raising concerns
Ensuring adequate nutrition, staying hydrated, and maintaining gentle exercise can mitigate this effect
It is one of the most extensively researched peptides in published preclinical literature and is widely studied across UK and international research environments
and healthy muscle, tendon, ligament, and wound healing